36. Galimberti, R., et al., Cutaneous aspergillosis: a report of six cases. Br J Dermatol, 1998. 139(3): p. 522-6.
37. Nucci, M. and E. Anaissie, Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis, 2002. 35(8): p. 909-20.
38. Martino, P., et al., Clinical patterns of Fusarium infections in immunocompromised patients. J Infect, 1994. 28 Suppl 1: p. 7-15.
39. Venditti, M., et al., Invasive Fusarium solani infections in patients with acute leukemia. Rev Infect Dis, 1988. 10(3): p. 653-60.
40. Glasgow, G.P., J.E. Marks, and J.H. Ogura, An endolaryngeal brachytherapy mould for a carcinoma of the larynx recurrent after surgery and radiation. Laryngoscope, 1983. 93(1): p. 111-2.
41. Lionakis, M.S. and D.P. Kontoyiannis, Fusarium infections in critically ill patients. Semin Respir Crit Care Med, 2004. 25(2): p. 159-69.
42. Guarro, J., et al., Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient. J Clin Microbiol, 2000. 38(9): p. 3460-2.
43. Hansson, C., K. Rosen, and I. Braide, Fusarium infection with unusual skin lesions in a patient with acute lymphocytic leukemia. Dermatology, 1995. 191(4): p. 333-5.
44. Watsky, K.L., Sporotrichoid nodules in an immunocompromised host. Cutaneous emboli of Fusarium. Arch Dermatol, 1995. 131(11): p. 1329, 1330.
45. Collins, M.S. and M.G. Rinaldi, Cutaneous infection in man caused by Fusarium moniliforme. Sabouraudia, 1977. 15(2): p. 151-60.
46. Pereiro, M., Jr., J. Labandeira, and J. Toribio, Plantar hyperkeratosis due to Fusarium verticillioides in a patient with malignancy. Clin Exp Dermatol, 1999. 24(3): p. 175-8.
47. Biglan AW, J.H.P.W.S., Endophthalmitis.En:PediatricInfectious Diseases, Principlesandpractice. 2002. 2a ed.: p.;p.1074-9.
48. Graybill, J.R., Antifungal drugs and resistance. Adv Exp Med Biol, 1995. 390: p. 217-34.
49. Walsh, T.J., et al., Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis, 1998. 26(6): p. 1383-96.
50. Wolff, M.A. and R. Ramphal, Use of amphotericin B lipid complex for treatment of disseminated cutaneous fusarium infection in a neutropenic patient. Clin Infect Dis, 1995. 20(6): p. 1568-9.
51. Letscher-Bru, V., et al., Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient. J Clin Microbiol, 2002. 40(3): p. 1100-2.
52. Walsh, T.J. and A.H. Groll, Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis, 1999. 1(4): p. 247-61.
53. Ghannoum, M.A. and D.M. Kuhn, Voriconazole — better chances for patients with invasive mycoses. Eur J Med Res, 2002. 7(5): p. 242-56.
54. Consigny, S., et al., Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient. Clin Infect Dis, 2003. 37(2): p. 311-3.
55. Paphitou, N.I., et al., In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results. Antimicrob Agents Chemother, 2002. 46(10): p. 3298-300.
56. Linares, M.J., et al., Susceptibility of filamentous fungi to voriconazole tested by two microdilution methods. J Clin Microbiol, 2005. 43(1): p. 250-3.
57. PerfectJ., In vitro activities of investigation al triazoles against Fusarium species:effects of inoculum size and incubation time on broth microdilution susceptibility test results. Clin Infect Dis, 2005. 40(Supl6): p.:S401-8.
58. Raad, II, et al., Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis, 2006. 42(10): p. 1398-403.
59. Nucci, M., et al., Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer, 2003. 98(2): p. 315-9.
60. Perdomo, H., et al., Spectrum of clinically relevant Acremonium species in the United States. J Clin Microbiol. 49(1): p. 243-56.
61. Lau, Y.L., et al., Invasive Acremonium falciforme infection in a patient with severe combined immunodeficiency. Clin Infect Dis, 1995. 20(1): p. 197-8.
62. Hoog, G., J. Guarro, J. Gené, y MJ Figueras, Atlas de los Hongos clínicas. 2000. 2 ª ed, vol. 1.
63. DH, L., Los Hongos medicamente importantes, una guia de identificacion AMS Washinton D.C., 1995. 3era edicion.
64. Garzoni, C. and J. Garbino, New azoles as first line therapy for Paecilomyces lilacinus in transplant patients. Transpl Infect Dis, 2008. 10(2): p. 149-50.
65. Pastor, F.J. and J. Guarro, Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect, 2006. 12(10): p. 948-60.
66. Cortez, K.J., et al., Infections caused by Scedosporium spp. Clin Microbiol Rev, 2008. 21(1): p. 157-97.
67. Nucci, M., Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis, 2003. 16(6): p. 607-12.
68. Caston, J.J., et al., Clinical differences between invasive pulmonary infection by Scedosporium apiospermum and invasive pulmonary aspergillosis. Mycoses. 54(5): p. e468-73.
69. Perfect, J.R., et al., Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis, 2003. 36(9): p. 1122-31.
70. Kuhls, K., et al., Molecular reidentification of human pathogenic Trichoderma isolates as Trichoderma longibrachiatum and Trichoderma citrinoviride. Med Mycol, 1999. 37(1): p. 25-33.
71. Alanio, A., et al., Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin. Clin Infect Dis, 2008. 46(10): p. e116-8.
72. Lagrange-Xelot, M., et al., Trichoderma fungaemia in a neutropenic patient with pulmonary cancer and human immunodeficiency virus infection. Clin Microbiol Infect, 2008. 14(12): p. 1190-2.
73. Vignon, M., et al., Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient. Bone Marrow Transplant. 46(9): p. 1276-7.
74. LiuK, H., .AmJClinPathol., PerfectJR,SchellWA.Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces and Acremonium species by histopathology. 1998(109: .): p. 45-54.
Autor:
Lilia Mercedes Acevedo Almendarez
Pasante de la Maestría en Micología Medica, Modalidad para extranjeros, julio 2012.Buenos Aires, Argentina.
Maestría en Micología Médica
Director: Dr. Ricardo Negroni
Coordinadores: Dra. Alicia Arechavala
Dr. Gustavo E. Giusiano
BUENOS AIRES ARGENTINA , JULIO 2012
UNIVERSIDAD DEL NORDESTE
FACULTAD DE MEDICINA
| Página siguiente |